EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV. (Gene therapy, 2006)

(untitled) - Balaggan, K; Binley, K; Esapa, M; Maclaren, R; Iqball, S; Duran, Y; Pearson, R; Kan, O; Barker, SE; Smith, A; Bainbridge, J; Naylor, S; et al.